TIDM37XJ

RNS Number : 8466R

Holmes Master Issuer plc

08 July 2022

HOLMES MASTER ISSUER PLC

(a public company incorporated with limited liability in England and Wales with registered number 05953811)

(the "Company")

Publication of Supplemental Prospectus

The following prospectus supplement has been approved by the UK Financial Conduct Authority and is available for viewing:

Supplement dated 8 July 2022 (the Supplement) to the prospectus dated 24 May 2022 relating to the Residential Mortgage-Backed Note Issuance Programme of Holmes Master Issuer plc (the Prospectus). The Supplement is available for viewing by clicking on or pasting the following URL into the address bar of your browser:

https://data.fca.org.uk/artefacts/NSM/Portal/NI-000055314/NI-000055314.pdf

A copy of the Supplement has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

The Supplement will also be available for viewing at:

https://www.santander.co.uk/about-santander/investor-relations/holmes-master-trust

For further information, please contact:

Medium Term Funding

Santander UK plc

2 Triton Square

Regent's Place

London

NW1 3AN

Email: mtf@santander.co.uk

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Supplement (and the Prospectus to which it relates) may be addressed to and/or targeted at persons who are residents of particular countries (as specified in the Supplement and the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Supplement and the Prospectus is not addressed. Prior to relying on the information contained in the Supplement and the Prospectus, you must ascertain from the Supplement and the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in, the United States of America, or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act) except to persons that are qualified institutional buyers within the meaning of Rule 144A under the Securities Act, or in transactions that occur outside the United States to persons other than U.S. persons in accordance with Regulation S, unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PSPEANXPESXAEEA

(END) Dow Jones Newswires

July 08, 2022 05:58 ET (09:58 GMT)

Grafico Azioni Holmes 54 A (LSE:37XJ)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Holmes 54 A
Grafico Azioni Holmes 54 A (LSE:37XJ)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Holmes 54 A